Hypercholesterolemia and inflammation—Cooperative cardiovascular risk factors
European Journal of Clinical Investigation · 2025-01 · 55 (1)
DOI: 10.1111/eci.14326 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift European Journal of Clinical Investigation, online erschienen am 06.10.2024. Verfasst von Antonio Gallo und 7 weiteren Autor:innen. Beteiligte Einrichtung: Lipidology and Cardiovascular Prevention Unit, Department of Nutrition, APHP, Hôpital Pitié-Salpètriêre, Sorbonne Université, INSERM UMR1166, Paris, …. Hauptthemen laut MEDLINE: Atherosclerosis, Cholesterol, LDL, Heart Disease Risk Factors, Hypercholesterolemia. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 227 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Italian Ministry of University and Research.
Abstract (Originalsprache)
Background
Maintaining low concentrations of plasma low‐density lipoprotein cholesterol (LDLc) over time decreases the number of LDL particles trapped within the artery wall, slows the progression of atherosclerosis and delays the age at which mature atherosclerotic plaques develop. This substantially reduces the lifetime risk of atherosclerotic cardiovascular disease (ASCVD) events. In this context, plaque development and vulnerability result not only from lipid accumulation but also from inflammation.
Results
Changes in the composition of immune cells, including macrophages, dendritic cells, T cells, B cells, mast cells and neutrophils, along with altered cytokine and chemokine release, disrupt the equilibrium between inflammation and anti‐inflammatory mechanisms at plaque sites. Considering that it is not a competition between LDLc and inflammation, but instead that they are partners in crime, the present narrative review aims to give an overview of the main inflammatory molecular pathways linked to raised LDLc concentrations and to describe the impact of lipid‐lowering approaches on the inflammatory and lipid burden. Although remarkable changes in LDLc are driven by the most recent lipid lowering combinations, the relative reduction in plasma C‐reactive protein appears to be independent of the magnitude of LDLc lowering.
Conclusion
Identifying clinical biomarkers of inflammation (e.g. interleukin‐6) and possible targets for therapy holds promise for monitoring and reducing the ASCVD burden in suitable patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Lipidology and Cardiovascular Prevention Unit, Department of Nutrition, APHP, Hôpital Pitié-Salpètriêre, Sorbonne Université, INSERM UMR1166, Paris, France.
- Academic Research Organization Hospital Israelita Albert Einstein and Lipid Clinic Heart Institute (InCor), University of Sao Paulo Medical School Hospital, Sao Paulo, Brazil.
- Department of Pharmacological and Biomolecular Sciences "Rodolfo Paoletti", Università degli Studi di Milano, Milan, Italy.
- Department of Cardio-Thoracic-Vascular Diseases, Foundation IRCCS Cà Granda Ospedale Maggiore Policlinico, Milan, Italy.
- Department of Clinical Sciences and Community Health, Università degli Studi di Milano, Milan, Italy.
ORCID-Profile: Massimiliano Ruscica
Förderung
- Italian Ministry of University and Research
Zitieren
APA
Gallo, A., Le Goff, W., Santos, R. D., Fichtner, I., Carugo, S., Corsini, A., Sirtori, C., & Ruscica, M. (2025). Hypercholesterolemia and inflammation—Cooperative cardiovascular risk factors. European Journal of Clinical Investigation, 55(1). https://doi.org/10.1111/eci.14326
Vancouver
Gallo A, Le Goff W, Santos RD, Fichtner I, Carugo S, Corsini A, et al. Hypercholesterolemia and inflammation—Cooperative cardiovascular risk factors. European Journal of Clinical Investigation. 2025;55(1). doi:10.1111/eci.14326
BibTeX
@article{Gallo2025,
author = {Gallo, Antonio and Le Goff, Wilfried and Santos, Raul D and Fichtner, Isabella and Carugo, Stefano and Corsini, Alberto and Sirtori, Cesare and Ruscica, Massimiliano},
title = {Hypercholesterolemia and inflammation—Cooperative cardiovascular risk factors},
journal = {European Journal of Clinical Investigation},
year = {2025},
volume = {55},
number = {1},
doi = {10.1111/eci.14326}
}
EUVIMED